![The Longevity Biotech Show](https://pbcdn1.podbean.com/imglogo/image-logo/11823068/Copy_of_Copy_of_Copy_of_Copy_of_Longevity_biotech_show_logoa90r5.png)
9.6K
Downloads
14
Episodes
A weekly live audience show featuring the people building and funding companies that are extending healthy human lifespan. Join us Thursdays on Clubhouse and check the show schedule on longevitybiotechshow.com Hosted by Nathan Cheng (founder @ Longevity Marketcap // Longevity List) and Robert Ziman (Cohen Lab).
Episodes
![#010: Jean Hebert (Albert Einstein College of Medicine, "Replacing Aging") - April 22nd, 2021](https://pbcdn1.podbean.com/imglogo/image-logo/11823068/Copy_of_Copy_of_Copy_of_Copy_of_Longevity_biotech_show_logoa90r5_300x300.png)
Thursday Apr 22, 2021
Thursday Apr 22, 2021
Jean Hebert is a professor of neurogenetics at Albert Einstein College of Medicine and the author of the book "Replacing Aging". We discuss his ambitious program to reverse aging in the brain by progressive replacement of neural tissue.
![#009: Keshav Singh & Greg Schmerge (Yuva Biosciences) - April 15th, 2021](https://pbcdn1.podbean.com/imglogo/image-logo/11823068/Copy_of_Copy_of_Copy_of_Copy_of_Longevity_biotech_show_logoa90r5_300x300.png)
Thursday Apr 15, 2021
#009: Keshav Singh & Greg Schmerge (Yuva Biosciences) - April 15th, 2021
Thursday Apr 15, 2021
Thursday Apr 15, 2021
Keshav Singh (University of Alabama) and Greg Schmergel (Nantero) are the co-founders of Yuva Biosciences, an early-stage biotech company developing drugs and natural compounds to reverse aging by targeting mitochondria.
![#008: Marc Bernegger, Tobias Reichmuth, Collin Ewald (Maximon) - April 8th, 2021](https://pbcdn1.podbean.com/imglogo/image-logo/11823068/Copy_of_Copy_of_Copy_of_Copy_of_Longevity_biotech_show_logoa90r5_300x300.png)
Thursday Apr 08, 2021
#008: Marc Bernegger, Tobias Reichmuth, Collin Ewald (Maximon) - April 8th, 2021
Thursday Apr 08, 2021
Thursday Apr 08, 2021
Marc Bernegger and Tobias Reichmuth are co-founders of Maximon, a longevity venture building company based in Switzerland. Collin Ewald is a professor at ETH Zurich, a world expert on extracellular matrix, and a scientific advisor at Maximon.
![#007: Daniel Ives (Shift Bioscience) - April 1st, 2021](https://pbcdn1.podbean.com/imglogo/image-logo/11823068/Copy_of_Copy_of_Copy_of_Copy_of_Longevity_biotech_show_logoa90r5_300x300.png)
Thursday Apr 01, 2021
#007: Daniel Ives (Shift Bioscience) - April 1st, 2021
Thursday Apr 01, 2021
Thursday Apr 01, 2021
Daniel Ives is the founder and CEO of Shift Bioscience, an early-stage longevity biotechnology company developing anti-aging drugs based on mitochondrial pathways and a single-cell epigenetics discovery platform.